Skip to main content
Top
Published in: BMC Nephrology 1/2013

Open Access 01-12-2013 | Research article

Protective effect of Erythropoietin on renal injury induced in rats by four weeks of exhaustive exercise

Authors: Xixiu Lin, Chonghe Jiang, Ziqiang Luo, Shulin Qu

Published in: BMC Nephrology | Issue 1/2013

Login to get access

Abstract

Background

The protective effect of Erythropoietin (EPO) analogue rHuEPO on acute renal injury induced by exhaustive exercise had been reported. The purpose of this study is to probe into the protective effect of EPO on chronic renal injury induced by repeated exhaustive exercise for four weeks.

Methods

Eighty adult male Sprague–Dawley rats were used in this experiment. The animals were randomly allocated to one of four groups: control (C), exhaustive exercise test (ET), ET plus EPO pre-treatement (ET+EPO) and ET+EPO plus LY294002 pretreatment (ET+EPO+LY).

Results

Compared with the rats in control group, there was considerable damage in kidney cells in rats of ET group as revealed by histological and ultrastructural examinations. However, treatment with EPO during the training, the exhaustive running distance was significant increased (P < 0.01), and the pathological changes of kidney cell were much less compared with those of rats without EPO intervention. When LY294002, a specific inhibitor of phospholipids phthalocyanine inositol 3-kinase, was added to the EPO treated rats, the injury changes of renal cell were becoming more pronounced.

Conclusions

The protective effect of EPO on chronic renal injury induced by repeated exhaustive exercise was demonstrated in the present study. We proposed that the effect could be due to inhibiting the cell apoptosis and blocking the formation of interstitial fibrosis via activation of the PI3K/Akt pathway, thus plays role in the endogenous protection of the kidney injury.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ates E, Yalcin AU, Yilmaz S, Koken T, Tokyol C: Protective effect of erythropoietin on renal ischemia and reperfusion injury. ANZ J Surg. 2005, 75: 1100-1105. 10.1111/j.1445-2197.2005.03612.x.CrossRefPubMed Ates E, Yalcin AU, Yilmaz S, Koken T, Tokyol C: Protective effect of erythropoietin on renal ischemia and reperfusion injury. ANZ J Surg. 2005, 75: 1100-1105. 10.1111/j.1445-2197.2005.03612.x.CrossRefPubMed
2.
go back to reference Dzietko M, Felderhoff-Mueser U, Sifringer M, Krutz B, Bittigau P, Thor F, Heumann R, Buhrer C: Erythropoietin protects the developing brain against N-methyl-D-aspartate receptor antagonist neurotoxicity. Neurobiol Dis. 2004, 15: 177-187. 10.1016/j.nbd.2003.10.006.CrossRefPubMed Dzietko M, Felderhoff-Mueser U, Sifringer M, Krutz B, Bittigau P, Thor F, Heumann R, Buhrer C: Erythropoietin protects the developing brain against N-methyl-D-aspartate receptor antagonist neurotoxicity. Neurobiol Dis. 2004, 15: 177-187. 10.1016/j.nbd.2003.10.006.CrossRefPubMed
3.
go back to reference Luo YH, Li ZD, Liu LX, Dong GH: Pretreatment with erythropoietin reduces hepatic ischemia-reperfusion injury. Hepatobiliary Pancreat Dis Int. 2009, 8: 294-299.PubMed Luo YH, Li ZD, Liu LX, Dong GH: Pretreatment with erythropoietin reduces hepatic ischemia-reperfusion injury. Hepatobiliary Pancreat Dis Int. 2009, 8: 294-299.PubMed
4.
go back to reference Klausen T: The feed-back regulation of erythropoietin production in healthy humans. Dan Med Bull. 1998, 45: 345-353.PubMed Klausen T: The feed-back regulation of erythropoietin production in healthy humans. Dan Med Bull. 1998, 45: 345-353.PubMed
5.
go back to reference Calvillo L, Latini R, Kajstura J, Leri A, Anversa P, Ghezzi P, Salio M, Cerami A: Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci U S A. 2003, 100: 4802-4806. 10.1073/pnas.0630444100.CrossRefPubMedPubMedCentral Calvillo L, Latini R, Kajstura J, Leri A, Anversa P, Ghezzi P, Salio M, Cerami A: Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci U S A. 2003, 100: 4802-4806. 10.1073/pnas.0630444100.CrossRefPubMedPubMedCentral
6.
go back to reference Hostetter TH, Troy JL, Brenner BM: Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int. 1981, 19: 410-415. 10.1038/ki.1981.33.CrossRefPubMed Hostetter TH, Troy JL, Brenner BM: Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int. 1981, 19: 410-415. 10.1038/ki.1981.33.CrossRefPubMed
7.
go back to reference Yang CW, Li C, Jung JY, Shin SJ, Choi BS, Lim SW, Sun BK, Kim YS: Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney. FASEB J. 2003, 17: 1754-1755.CrossRefPubMed Yang CW, Li C, Jung JY, Shin SJ, Choi BS, Lim SW, Sun BK, Kim YS: Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney. FASEB J. 2003, 17: 1754-1755.CrossRefPubMed
8.
go back to reference Cerami A: TNF and EPO: major players in the innate immune response: their discovery. Ann Rheum Dis. 2012, 71 (Supp II): i55-i59.CrossRefPubMed Cerami A: TNF and EPO: major players in the innate immune response: their discovery. Ann Rheum Dis. 2012, 71 (Supp II): i55-i59.CrossRefPubMed
9.
go back to reference Fishbane S, Ragolia L, Palaia T, Johnson B, Elzein H, Maesaka JK: Cytoprotection by darbepoetin/epoetin alfa in pig tubular and mouse mesangial cells. Kidney Int. 2004, 65: 452-458. 10.1111/j.1523-1755.2004.00400.x.CrossRefPubMed Fishbane S, Ragolia L, Palaia T, Johnson B, Elzein H, Maesaka JK: Cytoprotection by darbepoetin/epoetin alfa in pig tubular and mouse mesangial cells. Kidney Int. 2004, 65: 452-458. 10.1111/j.1523-1755.2004.00400.x.CrossRefPubMed
10.
go back to reference Harriss DJ, Atkinson G: Update - ethical standards in sport and exercise science research. Int J Sports Med. 2011, 32: 819-821.CrossRefPubMed Harriss DJ, Atkinson G: Update - ethical standards in sport and exercise science research. Int J Sports Med. 2011, 32: 819-821.CrossRefPubMed
11.
go back to reference Somani SM, Frank S, Rybak LP: Responses of antioxidant system to acute and trained exercise in rat heart subcellular fractions. Pharmacol Biochem Behav. 1995, 51: 627-634. 10.1016/0091-3057(94)00427-K.CrossRefPubMed Somani SM, Frank S, Rybak LP: Responses of antioxidant system to acute and trained exercise in rat heart subcellular fractions. Pharmacol Biochem Behav. 1995, 51: 627-634. 10.1016/0091-3057(94)00427-K.CrossRefPubMed
12.
go back to reference Li Q, Xiong Z, Zhang Q: Influence of melatonin on ultrastructure of liver cell and kidney distal convoluted tubule cell in endurance-trained mice after exhaustive exercise. Chin J Sports Med. 2004, 23: 404-405. Li Q, Xiong Z, Zhang Q: Influence of melatonin on ultrastructure of liver cell and kidney distal convoluted tubule cell in endurance-trained mice after exhaustive exercise. Chin J Sports Med. 2004, 23: 404-405.
13.
go back to reference Lin X, Qu S, Hu M, Jiang C: Protective effect of erythropoietin on renal injury induced by acute exhaustive exercise in the rat. Int J Sports Med. 2010, 31: 847-853. 10.1055/s-0030-1265205.CrossRefPubMed Lin X, Qu S, Hu M, Jiang C: Protective effect of erythropoietin on renal injury induced by acute exhaustive exercise in the rat. Int J Sports Med. 2010, 31: 847-853. 10.1055/s-0030-1265205.CrossRefPubMed
14.
go back to reference Segal R, Dayan M, Zinger H, Mozes E: Suppression of experimental systemic lupus erythematosus (SLE) in mice via TNF inhibition by an anti-TNFalpha monoclonal antibody and by pentoxiphylline. Lupus. 2001, 10: 23-31. 10.1191/096120301675275538.CrossRefPubMed Segal R, Dayan M, Zinger H, Mozes E: Suppression of experimental systemic lupus erythematosus (SLE) in mice via TNF inhibition by an anti-TNFalpha monoclonal antibody and by pentoxiphylline. Lupus. 2001, 10: 23-31. 10.1191/096120301675275538.CrossRefPubMed
15.
go back to reference Singbartl K, Green SA, Ley K: Blocking P-selectin protects from ischemia/reperfusion-induced acute renal failure. FASEB J. 2000, 14: 48-54.PubMed Singbartl K, Green SA, Ley K: Blocking P-selectin protects from ischemia/reperfusion-induced acute renal failure. FASEB J. 2000, 14: 48-54.PubMed
16.
go back to reference Schmid RA, Yamashita M: Effect of pentoxifylline in a canine and porcine model of pulmonary allograft reperfusion injury. J Heart Lung Transplant. 1997, 16: 366-367.PubMed Schmid RA, Yamashita M: Effect of pentoxifylline in a canine and porcine model of pulmonary allograft reperfusion injury. J Heart Lung Transplant. 1997, 16: 366-367.PubMed
17.
go back to reference Kaushal GP, Basnakian AG, Shah SV: Apoptotic pathways in ischemic acute renal failure. Kidney Int. 2004, 66: 500-506. 10.1111/j.1523-1755.2004.761_6.x.CrossRefPubMed Kaushal GP, Basnakian AG, Shah SV: Apoptotic pathways in ischemic acute renal failure. Kidney Int. 2004, 66: 500-506. 10.1111/j.1523-1755.2004.761_6.x.CrossRefPubMed
18.
go back to reference Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A: Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia. 1989, 32: 219-226.PubMed Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A: Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia. 1989, 32: 219-226.PubMed
19.
go back to reference Björn SF, Bangstad HJ, Hanssen KF, Nyberg G, Walker JD, Viberti GC, Osterby R: Glomerular epithelial foot processes and filtration slits in IDDM patients. Diabetologia. 1995, 38: 1197-1204. 10.1007/BF00422369.CrossRefPubMed Björn SF, Bangstad HJ, Hanssen KF, Nyberg G, Walker JD, Viberti GC, Osterby R: Glomerular epithelial foot processes and filtration slits in IDDM patients. Diabetologia. 1995, 38: 1197-1204. 10.1007/BF00422369.CrossRefPubMed
20.
go back to reference Blum S, Nakhoul F, Khankin E, Abassi Z: Renal slit diaphragm–the open zipper and the failing heart. Isr Med Assoc J. 2007, 9: 107-111.PubMed Blum S, Nakhoul F, Khankin E, Abassi Z: Renal slit diaphragm–the open zipper and the failing heart. Isr Med Assoc J. 2007, 9: 107-111.PubMed
21.
go back to reference Liu Z: Small deseases leading to nephropathy and focal segmental glomurular sclerosis. Beijing People’s Surg Press. 2008, 1: 364-386. Liu Z: Small deseases leading to nephropathy and focal segmental glomurular sclerosis. Beijing People’s Surg Press. 2008, 1: 364-386.
22.
go back to reference Zhou Q: Kidney tubules- interstitial hypoxia and progressive renal diseases. Central Chin Med J. 2001, 25: 79-80. Zhou Q: Kidney tubules- interstitial hypoxia and progressive renal diseases. Central Chin Med J. 2001, 25: 79-80.
23.
go back to reference Celik M, Gokmen N, Erbayraktar S, Akhisaroglu M, Konakc S, Ulukus C, Genc S, Genc K: Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc Natl Acad Sci U S A. 2002, 99: 2258-2263. 10.1073/pnas.042693799.CrossRefPubMedPubMedCentral Celik M, Gokmen N, Erbayraktar S, Akhisaroglu M, Konakc S, Ulukus C, Genc S, Genc K: Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc Natl Acad Sci U S A. 2002, 99: 2258-2263. 10.1073/pnas.042693799.CrossRefPubMedPubMedCentral
24.
go back to reference Patel NS, Sharples EJ, Cuzzocrea S, Chatterjee PK, Britti D, Yaqoob MM, Thiemermann C: Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo. Kidney Int. 2004, 66: 983-989. 10.1111/j.1523-1755.2004.00847.x.CrossRefPubMed Patel NS, Sharples EJ, Cuzzocrea S, Chatterjee PK, Britti D, Yaqoob MM, Thiemermann C: Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo. Kidney Int. 2004, 66: 983-989. 10.1111/j.1523-1755.2004.00847.x.CrossRefPubMed
25.
go back to reference Sharples EJ, Patel N, Brown P, Stewart K, Mota-Philipe H, Sheaff M, Kieswich J, Allen D: Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol. 2004, 15: 2115-2124. 10.1097/01.ASN.0000135059.67385.5D.CrossRefPubMed Sharples EJ, Patel N, Brown P, Stewart K, Mota-Philipe H, Sheaff M, Kieswich J, Allen D: Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol. 2004, 15: 2115-2124. 10.1097/01.ASN.0000135059.67385.5D.CrossRefPubMed
26.
go back to reference Vesey DA, Cheung C, Pat B, Endre Z, Gobe G, Johnson DW: Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant. 2004, 19: 348-355. 10.1093/ndt/gfg547.CrossRefPubMed Vesey DA, Cheung C, Pat B, Endre Z, Gobe G, Johnson DW: Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant. 2004, 19: 348-355. 10.1093/ndt/gfg547.CrossRefPubMed
27.
go back to reference Lin X, Qu S: Influence of hypoxia training on rats’ kidney cell apoptosis and correlation factor. Hunan Normal University Press. 2008, 1: 1-2. Lin X, Qu S: Influence of hypoxia training on rats’ kidney cell apoptosis and correlation factor. Hunan Normal University Press. 2008, 1: 1-2.
28.
go back to reference Chen SF, Tsai HJ, Hung TH, Chen CC, Lee CY, Wu CH, Wang PY, Liao NC: Salidroside improves behavioral and histological outcomes and reduces apoptosis via PI3K/Akt signaling after experimental traumatic brain injury. PLoS One. 2012, 7: e45763(1)-e45763(5). Chen SF, Tsai HJ, Hung TH, Chen CC, Lee CY, Wu CH, Wang PY, Liao NC: Salidroside improves behavioral and histological outcomes and reduces apoptosis via PI3K/Akt signaling after experimental traumatic brain injury. PLoS One. 2012, 7: e45763(1)-e45763(5).
29.
go back to reference Graves BM, Simerly T, Li C, Williams DL, Wondergem R: Phosphoinositide-3-kinase/akt - dependent signaling is required for maintenance of [Ca(2+)](i), I(Ca), and Ca(2+) transients in HL-1 cardiomyocytes. J Biomed Sci. 2012, 20: 19-59. Graves BM, Simerly T, Li C, Williams DL, Wondergem R: Phosphoinositide-3-kinase/akt - dependent signaling is required for maintenance of [Ca(2+)](i), I(Ca), and Ca(2+) transients in HL-1 cardiomyocytes. J Biomed Sci. 2012, 20: 19-59.
30.
go back to reference Siragusa M, Katare R, Meloni M, Damilano F, Hirsch E, Emanueli C, Madeddu P: Involvement of phosphoinositide 3-kinase gamma in angiogenesis and healing of experimental myocardial infarction in mice. Circ Res. 2010, 106: 757-768. 10.1161/CIRCRESAHA.109.207449.CrossRefPubMedPubMedCentral Siragusa M, Katare R, Meloni M, Damilano F, Hirsch E, Emanueli C, Madeddu P: Involvement of phosphoinositide 3-kinase gamma in angiogenesis and healing of experimental myocardial infarction in mice. Circ Res. 2010, 106: 757-768. 10.1161/CIRCRESAHA.109.207449.CrossRefPubMedPubMedCentral
Metadata
Title
Protective effect of Erythropoietin on renal injury induced in rats by four weeks of exhaustive exercise
Authors
Xixiu Lin
Chonghe Jiang
Ziqiang Luo
Shulin Qu
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2013
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-14-130

Other articles of this Issue 1/2013

BMC Nephrology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.